Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 USD | +29.55% | +31.54% | +189.83% |
21/05 | DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis | CI |
21/05 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+189.83% | 5.31Cr | |
+11.91% | 12TCr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.15% | 2.2TCr | |
-9.23% | 1.82TCr | |
-42.12% | 1.64TCr | |
-17.47% | 1.56TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr |
- Stock Market
- Equities
- DRRX Stock
- News DURECT Corporation
- Durect Gets FDA Breakthrough Therapy Designation for Alcohol-Related Hepatitis Treatment